H1B Report
H-1B sponsorKYFEIN 26-4183569Updated Sep 2026

King's Daughters Medical Specialties, Inc.

US H-1B Labor Condition Application activity for King's Daughters Medical Specialties, Inc.. Filed 65 disclosures between FY2011 and FY2026 from worksites with a KY headquarters indicator.

Total filings
9
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of King's Daughters Medical Specialties, Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 92.3%, Cert-withdrawn 3.1%, Denied 4.6%
Outcome breakdown
OutcomeShare
Certified92.3%
Cert-withdrawn3.1%
Denied4.6%
Certified92.3%
Cert-withdrawn3.1%
Denied4.6%

Top occupations sponsored

SOC codes filed most by King's Daughters Medical Specialties, Inc. across all fiscal years. Click any row to open the national salary guide.

#SOCTitleFilings
129-1229Physicians, All Other40
229-1249Surgeons, All Other11
329-1212Cardiologists7
429-1217Neurologists4
529-1216General Internal Medicine Physicians2
629-1215Family Medicine Physicians1

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY20119
FY20122
FY20135
FY20145
FY20156
FY20163
FY20177
FY20199
FY20244
FY20256
FY20269
Time series: 11 points from FY2011 to FY2026
Time series
PeriodValue
FY20119
FY20122
FY20135
FY20145
FY20156
FY20163
FY20177
FY20199
FY20244
FY20256
FY20269

This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.

Compare King's Daughters Medical Specialties, Inc. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.